Senate panel approves pharmacy rule rewrite but removes state compounding labeling language
The Senate Health and Welfare Committee approved a broad rewrite of Idaho Board of Pharmacy rules but voted to strike specific state labeling language for distributed compounded drug products amid stakeholder concern and federal uncertainty.
The full story
The Senate Health and Welfare Committee voted to approve a comprehensive rewrite of Idaho State Board of Pharmacy rules (docket 24-3601-2402) on a motion that removed a narrow compounding-labeling provision after committee members raised concerns about regulatory conflict with unsettled federal guidance.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or